Eton Pharmaceuticals, Inc.

ETON · Nasdaq · SIC 2834: Pharmaceutical Preparations
191
SEC Filings

Business Summary

PART I About Eton Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. We currently have eightcommercial rare disease products: INCRELEX, ALKINDI SPRINKLE, KHINDIVI TM ,GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. Wehave five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector. INCRELEX This biologic product was approved by the FDA ...

Next Earnings

Q2 FY2026 — expected 2026-08-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionETONdiscussed_in_filing Artificial Intelligence
topic_mentionETONdiscussed_in_filing Cybersecurity
topic_mentionETONdiscussed_in_filing Trusted Computing
topic_mentionETONdiscussed_in_filing Blockchain & Crypto
topic_mentionETONdiscussed_in_filing Supply Chain
topic_mentionETONdiscussed_in_filing Regulation
topic_mentionETONdiscussed_in_filing Healthcare & Bio
topic_mentionETONdiscussed_in_filing AI Compute
topic_mentionETONdiscussed_in_filing Sovereign & Government
topic_mentionETONdiscussed_in_filing Artificial Intelligence
topic_mentionETONdiscussed_in_filing Cybersecurity
topic_mentionETONdiscussed_in_filing Trusted Computing
topic_mentionETONdiscussed_in_filing Blockchain & Crypto
topic_mentionETONdiscussed_in_filing Supply Chain
topic_mentionETONdiscussed_in_filing Regulation
topic_mentionETONdiscussed_in_filing Healthcare & Bio
topic_mentionETONdiscussed_in_filing AI Compute
topic_mentionETONdiscussed_in_filing Sovereign & Government
topic_mentionETONdiscussed_in_filing Artificial Intelligence
topic_mentionETONdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001437749-26-009059EDGAR62K words
2025-03-182024-12-310001437749-25-008136EDGAR—
2024-03-142023-12-310001437749-24-007853EDGAR—
2023-03-162022-12-310001493152-23-007933EDGAR—
2022-03-162021-12-310001493152-22-006990EDGAR—
2021-03-162020-12-310001493152-21-006122EDGAR—
2020-03-052019-12-310001493152-20-003451EDGAR—
2019-03-252018-12-310001493152-19-003817EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001437749-25-033619EDGAR22K words
2025-08-072025-06-300001437749-25-025444EDGAR—
2025-05-132025-03-310001437749-25-016475EDGAR—
2024-11-122024-09-300001437749-24-034567EDGAR—
2024-08-082024-06-300001437749-24-025574EDGAR—
2024-05-092024-03-310001437749-24-015697EDGAR—
2023-11-092023-09-300001437749-23-031284EDGAR—
2023-08-102023-06-300001437749-23-023067EDGAR—
2023-05-112023-03-310001437749-23-013951EDGAR—
2022-11-102022-09-300001493152-22-031373EDGAR—
2022-08-112022-06-300001493152-22-022100EDGAR—
2022-05-122022-03-310001493152-22-013047EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001437749-26-009060EDGAR7K words
2026-03-020001437749-26-006209EDGAR—
2026-02-250001437749-26-005537EDGAR—
2026-02-020001437749-26-002605EDGAR—
2025-12-040001437749-25-036853EDGAR—
2025-11-060001437749-25-033616EDGAR—
2025-08-070001437749-25-025438EDGAR—
2025-07-080001437749-25-022298EDGAR—
2025-06-270001437749-25-021383EDGAR—
2025-06-200001437749-25-020916EDGAR—

191 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001710340
TickerETON
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 10cb351d45b8a516e9fc8cd3375d9291e83b17fefcc62ffd56629bb4f2ae0b25
parent: 04582f8e4544a48638ac716d1b98f36e4d49258cbe8e0dc3010e17bf68c27c9f
content hash: 2d3fe4d477ab8250df45e4ea6207c9fa975fefe6429df1080e859d5d8b54bd56
signed: 2026-04-13T04:44:55.584Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf